Enhanced inhibition of Avian leukosis virus subgroup J replication by multi-target miRNAs

Virology Journal

Zhi-Guang Xiao¹  Jin Tian¹  Wei Wang¹  Zai-Ping Zhang¹  Qing-Wen Meng¹ 

[1] State Key Laboratory of Veterinary Biotechnology,Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, No.427 Maduan Street, Nangang District, Harbin 150001, People's Republic of China

关键词: Multi-target series;    Gag;    Inhibition;    miRNA;    ALV;   

Others  :  1155367
DOI  :  10.1186/1743-422X-8-556

 received in 2011-06-08, accepted in 2011-12-22,  发布年份 2011

【 摘 要 】

Background

Avian leukosis virus (ALV) is a major infectious disease that impacts the poultry industry worldwide. Despite intensive efforts, no effective vaccine has been developed against ALV because of mutations that lead to resistant forms. Therefore, there is a dire need to develop antiviral agents for the treatment of ALV infections and RNA interference (RNAi) is considered an effective antiviral strategy.

Results

In this study, the avian leukosis virus subgroup J (ALV-J) proviral genome, including the gag genes, were treated as targets for RNAi. Four pairs of miRNA sequences were designed and synthesized that targeted different regions of the gag gene. The screened target (i.e., the gag genes) was shown to effectively suppress the replication of ALV-J by 19.0-77.3%. To avoid the generation of escape variants during virus infection, expression vectors of multi-target miRNAs were constructed using the multi-target serial strategy (against different regions of the gag, pol, and env genes). Multi-target miRNAs were shown to play a synergistic role in the inhibition of ALV-J replication, with an inhibition efficiency of viral replication ranging from 85.0-91.2%.

Conclusion

The strategy of multi-target miRNAs might be an effective method for inhibiting ALV replication and the acquisition of resistant mutations.

【 授权许可】

   
2011 Meng et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Zhang L-J, Liu J, Cheng Z-Q, Wang G-H, Diao X-G, Zhu G: Detecting avian leukosis virus subgroup J using tissue chip and immunohistochemical technology. Chin J Prevent Vet Med 2006, 4:427-430.
• [2]Nielsen MH, Pedersen FS, Kjims J: Molecular strategies to inhibit HIV-1 replication. Retrovirology 2005, 2:10. BioMed Central Full Text
• [3]Lee NS, Dohjima T, Bauer G, Li G, Li MJ, Ehsani A, Salvaterra P, Rossi J: Expression of small interfering RNAs targeted against HIV21 rev transcripts in human cells. Nat Biotechnol 2002, 20:500-505.
• [4]Sagan SM, Nasheri N, Luebbert C, Pezacki JP: The efficacy of siRNA against hepatitis C virus is Strongly influenced by structure and target site accessibility. Chem Biol 2010, 17:515-27.
• [5]Christophe C, Saulnier A, Benureau Y, Flechet D, Delgrange D, Colbere-Garapin F, Wychowski C, Martin A: Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs. Mol Ther 2007, 15(8):1452-1462.
• [6]McCaff rey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Marion PL, Kay MA: Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003, 21:639-644.
• [7]Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD: Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002, 12(15):1301-1311.
• [8]Chen M, Granger AJ, VanBrocklin MW: Inhibition of avian leukosis virus replication by vector-based RNA interference. Virology 2007, 365:464-472.
• [9]Himly M, Foster DN, Bottoli I, lacovoni JS, Vogt PK: The DF1 chicken fibroblast cell liner: transformation induced by diverse oncogene and cell death resulting from infection by avian leukosis viruses. Virology 1998, 248:295-304.
• [10]Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hygiene 1938, 27(3):493-497.
• [11]Wu K, Mu Y, Hu J, Lu L, Zhang X, Yang Y, Li Y, Liu F, Song D, Zhu Y, Wu J: Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system. Antiviral Res 2007, 74(2):142-149.
• [12]Randall G, Rice CM: Interfering with hepatitis C virus RNA replication. Virus Res 2004, 102:19-25.
• [13]Coburn GA, Cullen BR: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002, 76(18):9225-31.
• [14]Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J: RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcriptioin. Proc Natl Acad Sci USA 2003, 100:2718-2723.
• [15]Chen W, Yan W, Du Q, Fei L, Liu M, Ni Z, Sheng Z, Zheng Z: RNA interference targeting VP1 inhibits foot-and mouth disease virus replication in BHK-21 cells and suckling mice. J Virol 2004, 78:6900-6907.
• [16]Liu M, Chen W, Ni Z, Yan W, Fei L, Jiao Y, Zhang J, Du Q, Wei X, Chen J, Liu Y, Zheng Z: Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. Virology 2005, 336:51-59.
• [17]Lu A, Zhang H, Zhang X, Wang H, Hu Q, Shen L, Schaffhausen BS, Hou W, Li L: Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase. Virology 2004, 324(1):84-89.
• [18]Jia Q, Sun R: Inhibition of gammaherpesvirus replication by RNA interference. J Virol 2003, 77:3301-3306.
• [19]Bhuyan PK, Kariko K, Capodici J, Lubinski J, Hook LM, Friedman HM, Weissman D: Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. J Virol 2004, 78:10276-10281.
• [20]Wiebusch L, Truss M, Hagemeier C: Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol 2004, 85:179-184.
• [21]Mallanna SK, Rasool TJ, Sahay B, Aleyas AG, Ram H, Mondal B, Nautiyal B, Premrai A, Sreekumar E, Yadav MP: Inhibition of Anatid Herpes Virus-1 replication by small interfering RNAs in cell culture system. Virus Res 2006, 115:192-197.